TCL Archive Investigation finds no evidence FDA’s Crawford had affair with subordinate. June 10, 2005
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications July 22, 2011